SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-008731
Filing Date
2021-01-28
Accepted
2021-01-28 15:34:17
Documents
9
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm213818d1_10q.htm 10-Q 452428
2 EXHIBIT 3.1 tm213818d1_ex3-1.htm EX-3.1 64545
3 EXHIBIT 3.2 tm213818d1_ex3-2.htm EX-3.2 212385
4 EXHIBIT 10.1 tm213818d1_ex10-1.htm EX-10.1 111601
5 EXHIBIT 31.1 tm213818d1_ex31-1.htm EX-31.1 10433
6 EXHIBIT 31.2 tm213818d1_ex31-2.htm EX-31.2 10401
7 EXHIBIT 32.1 tm213818d1_ex32-1.htm EX-32.1 4750
8 EXHIBIT 32.2 tm213818d1_ex32-2.htm EX-32.2 4780
9 GRAPHIC tm213818d1_ex3-1img01.jpg GRAPHIC 11639
  Complete submission text file 0001104659-21-008731.txt   888602
Mailing Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170 (212) 479-2513
Scopus BioPharma Inc. (Filer) CIK: 0001772028 (see all company filings)

IRS No.: 821248020 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39788 | Film No.: 21564702
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences